NCT00472368
- Conditions
- Cancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological Malignancies, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
- Locations
-
- Novartis Investigative Site Buffalo, New York, United States